
DCM Shriram will invest up to ₹105 crore for a 26% stake in Serentica's 58 MW hybrid project, targeting 176 MW total renewable capacity by June 2027.
DCM Shriram Ltd signed a definitive agreement with Serentica Renewables India 38 Pvt Ltd to develop a 58 MW (peak) hybrid renewable energy project for its Bharuch chemical operations in Gujarat, the company said in a press release.
The project combines solar power from Rajasthan and wind power from Karnataka. Serentica will supply 58 MW of renewable power to DCM Shriram Chemicals' Bharuch plant through a 190 MW renewable energy project. The facility is expected to be commissioned by June 2027.
DCM Shriram will invest up to ₹105 crore, in one or more tranches, to acquire a minimum 26% equity stake in the special purpose vehicle. The investment will increase the company's total renewable energy capacity to 176 MW (peak) across its Bharuch and Kota facilities.
Nandy added that the project is expected to help avoid nearly 0.4 million tonnes of CO₂ emissions annually while improving cost efficiency by increasing the use of renewable power. The company also said the project provides greater visibility into long-term power costs and reduces exposure to fluctuations in conventional energy prices.
The deal reflects a broader push among Indian chemical manufacturers to secure renewable power for energy-intensive processes. DCM Shriram's chemical division consumes significant electricity for operations at Bharuch and Kota, and the hybrid structure – pairing solar from Rajasthan with wind from Karnataka – helps smooth intermittent supply.
Once commissioned, the project is expected to improve energy efficiency and reduce emissions, contributing to a more sustainable manufacturing base, the release said.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.